Ranibizumab versus aflibercept for diabetic macular edema: 18-month results of a comparative, prospective, randomized study and multivariate analysis of visual outcome predictors-Reference-Cited by-同舟云学术

Ranibizumab versus aflibercept for diabetic macular edema: 18-month results of a comparative, prospective, randomized study and multivariate analysis of visual outcome predictors

Published:2020-08-09 Issue:4 Volume:39 Page:317-322
ISSN:1556-9527
Container-title:Cutaneous and Ocular Toxicology
language:en
Short-container-title:Cutaneous and Ocular Toxicology

Author:

Chatzirallis Alexandros¹,Theodossiadis Panagiotis²,Droutsas Konstantinos³,Koutsandrea Chryssanthi³,Ladas Ioannis³,Moschos Marilita M.³

Affiliation:

1. 2nd Department of Ophthalmology, Ophthalmiatrion Athinon, Athens, Greece

2. 2nd Department of Ophthalmology, National and Kapodistrian University of Athens, Athens, Greece

3. 1st Department of Ophthalmology, National and Kapodistrian University of Athens, Athens, Greece

Publisher

Informa UK Limited

Subject

Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/15569527.2020.1802741

Reference27 articles.

1. Global Prevalence and Major Risk Factors of Diabetic Retinopathy

2. Diabetic retinopathy

3. The Wisconsin Epidemiologic Study of Diabetic Retinopathy XV

4. Diabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets

5. Mechanisms of macular edema: Beyond the surface

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravitreal Antiangiogenic Treatment for Diabetic Retinopathy: A Mexican Real-Life Scenario Experience;Life;2024-08-02

2. Comparative Efficacy, Durability and Safety of Faricimab in the Treatment of Diabetic Macular Edema: A Systematic Literature Review and Network Meta-Analysis;Advances in Therapy;2023-09-26

3. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis;Cochrane Database of Systematic Reviews;2023-06-27

4. Aflibercept versus ranibizumab for diabetic macular edema: A meta-analysis;European Journal of Ophthalmology;2023-05-24

5. Efficacy and Safety of Brolucizumab, Aflibercept, and Ranibizumab for the Treatment of Patients with Visual Impairment Due to Diabetic Macular Oedema: A Systematic Review and Network Meta-Analysis;Diabetes Therapy;2023-05-17